|

FX-111 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Flare Therapeutics Inc.1

Indications

  • Neoplasms of Prostate1
  • mCRPC or Advanced/Metastatic Solid Tumors1
  • Neoplasms Prostate1
  • Prostatic Neoplasms, Castration-Resistant1
  • mCRPC1

Los Angeles, California1 trial

A Study in Patients With Metastatic Castration-Resistant Prostate Cancer

START Los Angeles

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.